Becton Dickinson Dividend Stock Analysis
by | Posted 3.12.2013 | Post Comment (No Comments)

Becton, Dickinson & Co. (BDX) is a healthcare company operating in three segments. The medical segment manufactures a variety of medical devices and accounted for 53% of 2012 sales. The diagnostics segment provides products for the safe collection and transport of lab specimens as well as tools used to detect infectious diseases and cancers. The diagnostics segment accounted for 33% of 2012 sales. The biosciences segment produces research and clinical tools that help in the study of cells. This last segment accounts for 14% of 2012 sales

Read the rest of this post @ Dividends4Life